Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitis. - Wikidata - awgldk - TriplyDB

Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitis.

Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitis.

http://www.wikidata.org/entity/Q37578381

about

Historical review of the causes of cancer Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma Liver resection and transplantation in hepatocellular carcinoma Surgical approach for hepatitis C virus-related hepatocellular carcinoma Adjuvant therapy after curative resection for hepatocellular carcinoma associated with hepatitis virus Adoptive immunotherapy in postoperative hepatocellular carcinoma: a systemic review Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver function Surgical outcomes of hepatocellular carcinoma with biliary tumor thrombus: a systematic review Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Immunological HCV-associated thrombocytopenia: short review Evaluated outcomes in patients with Chronic Hepatitis C.Eastern Asian expert panel opinion: designing clinical trials of molecular targeted therapy for hepatocellular carcinoma Adjuvant interferon for early or late recurrence of hepatocellular carcinoma and mortality from hepatocellular carcinoma following curative treatment: A meta-analysis with comparison of different types of hepatitis Preclinical evaluation of recombinant human IFNα2b-containing magnetoliposomes for treating hepatocellular carcinoma.Peretinoin, an acyclic retinoid, improves the hepatic gene signature of chronic hepatitis C following curative therapy of hepatocellular carcinoma.p53-paralog DNp73 oncogene is repressed by IFNα/STAT2 through the recruitment of the Ezh2 polycomb group transcriptional repressor.Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled study.Efficacy of 24-week pegylated interferon alpha and ribavirin combination therapy in highly selected patients infected with hepatitis C virus genotype 1.Optimal duration of treatment for HCV genotype 1 infection in slow responders: a meta-analysis.Optimal adjuvant therapy for resected hepatocellular carcinoma: a systematic review with network meta-analysis.Survey of survival among patients with hepatitis C virus-related hepatocellular carcinoma treated with peretinoin, an acyclic retinoid, after the completion of a randomized, placebo-controlled trial.Management of Hepatocellular Carcinoma: Current Status and Future Directions.Management of hepatocellular carcinoma: an overview of major findings from meta-analyses Low dose ribavirin for treatment of hepatitis C virus infected thalassemia major patients; new indications for combination therapy Real response to therapy in chronic hepatitis C virus patients: a study from iran.Interferon-γ induces autophagy with growth inhibition and cell death in human hepatocellular carcinoma (HCC) cells through interferon-regulatory factor-1 (IRF-1)Effects of antiviral therapy on the recurrence of hepatocellular carcinoma after curative resection or liver transplantation.Current concepts in hepatic resection for hepatocellular carcinoma in cirrhotic patients Current status of multimodal & combination therapy for hepatocellular carcinoma.A meta-analysis of adjuvant therapy after potentially curative treatment for hepatocellular carcinoma.Postoperative aspartate aminotransferase to platelet ratio index change predicts prognosis for hepatocellular carcinoma Prevention of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.Adjuvant therapy after curative treatment for hepatocellular carcinoma.Impact of erythropoietin on sustained virological response to peginterferon and ribavirin therapy for HCV infection: a systematic review and meta-analysis.HCC: current surgical treatment concepts.A critical evaluation of the preventive effect of antiviral therapy on the development of hepatocellular carcinoma in patients with chronic hepatitis C or B: a novel approach by using meta-regression.Recurrent hepatocellular carcinoma after liver transplantation - an emerging clinical challenge.Medical therapies for hepatocellular carcinoma: a critical view of the evidence.Prevention of recurrence after curative treatment for hepatocellular carcinoma.

P2860

Q26767036-3FC11660-499A-4DB5-8EC7-0CAAE689E060 Q26799056-56326FCE-347A-45A5-81AF-CFA51CEB6C2E Q26823395-B715D4D8-2937-45B2-8937-B307374C1B74 Q26824046-2D4B4BCC-387F-4904-8A3E-65192A6A4FDD Q26829868-E72C2E85-0586-4EB6-853E-B6B0D9A13DD0 Q27026977-C2CC8745-03A8-44FA-A9B0-695FC2FBF59A Q28066295-F9301CDE-C04A-41BE-8D5E-B33F20F3E63A Q28079752-1E82D44F-7D47-4CFD-856B-9BAF75E5174D Q28272678-C46B959D-667D-4D42-B224-9E16DF517888 Q30391932-AD22C273-A7CA-43C5-8EC1-A514461BAD61 Q33402517-60D64E76-E5AA-4668-9205-C2E6D91D6B0D Q33596752-BCFE83B2-886E-4AC1-BD0A-70F810763CFB Q33742856-FC23DE91-4E65-45D8-A15F-65784ACE0B86 Q34265805-8C5E560B-A48B-4DE4-ADAD-D8223428AF1A Q34285853-95DE437A-B4E2-4149-8DB6-BCB1F586C530 Q34669200-68D559BE-D5AB-4577-87D7-3B667EAE93D2 Q35042810-97198203-CEA6-4FA4-AFDB-89543034DBD8 Q35055436-95E282CE-35F3-4666-90A9-9A8FC48844ED Q35089901-66E5E039-7F75-4EAA-B703-DE920EB73E49 Q35582452-C337267C-12C3-4FF8-8457-CEF74BF553E0 Q35660038-BEF3C034-2422-4EE9-98F1-CA21220B29AF Q35698198-AA0DA7D5-19CB-4EAE-B554-FDD9D047568E Q35771842-55286A3F-7D9F-4299-96BE-B1609C5BC7AB Q36014255-0C1F1685-551B-4027-B273-2C9AA55AC6D7 Q36142737-7CA97B15-7919-4537-BF97-14C08D95DBEE Q36329140-407291D7-18FF-43BB-B876-29A12610856B Q36366414-74C9C1A4-31BF-4199-ACCD-E702537DE10F Q36406952-1DF19190-F9FF-4817-BCC1-D31967FD6335 Q36429818-6E1C4CCB-0159-482D-8E8C-C71F5C73DABC Q36436294-9663E22F-7BDB-4845-A7C0-A8CB276CAA6C Q36934253-33404A14-4869-450E-88B4-61E2416EE6D9 Q37605578-E434636A-20C0-4CCF-A0F3-E7B1F300F2C6 Q37972806-88C5889C-40D2-49B2-B1A9-3AD54B48C968 Q37972807-4642207B-56C7-43BD-87E3-D37048565CE0 Q37975254-5FEA2ED6-2120-4C8F-A78B-559DB234F670 Q37980015-910445B3-9355-46E7-A68B-133CF1CF8677 Q38007308-2BA6D325-E0FF-4BB7-9DD5-9FDC7309C202 Q38045000-308428AB-B85C-4306-B1D5-1A449AED3D77 Q38059437-A06CB032-7F22-4DBD-9231-CEEF007DD0C1 Q38070128-D3B375F3-2858-457A-BAF8-016B8CC7C46E

P2860

Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitis.

http://www.wikidata.org/entity/Q37578381

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Systematic review and meta-ana ...... patients with viral hepatitis.

@en

Systematic review and meta-ana ...... patients with viral hepatitis.

@nl

type

label

Systematic review and meta-ana ...... patients with viral hepatitis.

@en

Systematic review and meta-ana ...... patients with viral hepatitis.

@nl

prefLabel

Systematic review and meta-ana ...... patients with viral hepatitis.

@en

Systematic review and meta-ana ...... patients with viral hepatitis.

@nl

P1433

Q37578381-F00403A5-6887-41CB-8A0F-E037E3CA61FC

P1476

Q37578381-A95BF0C5-31E9-49E9-AE61-F43F76047541

P2093

Q37578381-462B0BA8-B859-4682-901C-A6149E168499

Q37578381-52838B7C-A742-4455-B339-2D07934D9D38

Q37578381-64255862-A7CB-41B5-B523-8E2A4B6A8F94

Q37578381-95B201D3-594F-448E-B0BA-BBB1CAC65546

Q37578381-A1270AFE-31B8-4E19-B271-EEBFB4526E95

P2860

Q37578381-12778F65-2EC5-4441-A0A5-163786517778

Q37578381-31155DC4-6778-4705-96B9-66202BC797F2

P304

Q37578381-AB01B280-565F-43F1-B1F3-34BCB5AFB2F5

P31

Q37578381-E67B5953-4AD2-4572-BD55-721A7E613146

Q37578381-bbb99b56-c733-49b9-902e-88878d71527b

P356

Q37578381-0C107CAC-B401-41BB-BA59-135153662810

P407

Q37578381-9104D593-D2FA-494D-8FFD-65B87323212B

P433

Q37578381-CAD99B10-36BD-423B-A36A-F189C3AF6205

P478

Q37578381-CC4543BE-6CE0-47E2-A57F-6EBFF2F3EF66

P50

Q37578381-CBC0C7AF-2189-4EB9-AC91-0843E563A0E6

P577

Q37578381-8AA8622C-8A1A-428E-AADF-AEB95FE7FA4C

P5875

Q37578381-EA0DA4E7-EE25-40D0-B489-9F29BC28DC2E

P698

Q37578381-6A8A67D2-87CC-4ED5-855A-43BC2370A61F

P921

Q37578381-A300E66B-598A-4309-A3F5-60F759164753

Q37578381-EB34D17A-E60D-4825-BEA1-72F1D4BF2BB7

P356

P1433

British Journal of Surgery

P1476

Systematic review and meta-ana ...... patients with viral hepatitis

@en

P2093

D Dimitroulis

http://www.w3.org/2001/XMLSchema#string

H Petrowsky

http://www.w3.org/2001/XMLSchema#string

M A Puhan

http://www.w3.org/2001/XMLSchema#string

P-A Clavien

http://www.w3.org/2001/XMLSchema#string

S Breitenstein

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection.

Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus.

P304

975-981

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/BJS.6731

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26734420

http://www.w3.org/2001/XMLSchema#string

P698

19672926

http://www.w3.org/2001/XMLSchema#string

P921